NCT01583803

Brief Summary

Females have a lower incidence of hypertensive and cardiovascular disorders that may relate to differences in nitrogen oxides in the blood and saliva. Some nitrogen oxides are recycled with the help of oral bacteria to nitric oxide which is protective against vascular disorders. This study will test the hypothesis that females have different numbers and species of these nitrogen-oxide reducing bacteria.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 20, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 24, 2012

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2012

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
3.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

December 21, 2016

Status Verified

December 1, 2016

Enrollment Period

1.6 years

First QC Date

April 20, 2012

Last Update Submit

December 20, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Bacterial species identification

    At baseline

Secondary Outcomes (4)

  • Bacterial count

    At baseline

  • Blood pressure

    At baseline

  • Nitrogen oxide levels in biological fluids

    At baseline

  • Oral nitrate reduction

    At baseline

Study Arms (2)

Males

Females

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Community sample

You may qualify if:

  • Healthy subjects aged 18-45 who have volunteered themselves and are willing to sign the consent form

You may not qualify if:

  • Healthy subjects unwilling to consent
  • History of hypertension, diabetes or hypertensive on BP measurement
  • Pregnant, or any possibility that a subject may be pregnant unless in the latter case a pregnancy test is performed with a negative result
  • History of any serious illnesses, including recent infections or trauma
  • Subjects taking systemic medication (other than the oral contraceptive pill)
  • Subjects with self-reported use of mouthwash or tongue scrapes
  • Subjects with recent or current antibiotic use (within 3 months)
  • Subjects with a history, or recent treatment of (within last 3 months) of any oral condition (excluding caries), including gingivitis, periodontitis and halitosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

William Harvey Heart Centre

London, EC1M 6BQ, United Kingdom

Location

Related Publications (2)

  • Kapil V, Milsom AB, Okorie M, Maleki-Toyserkani S, Akram F, Rehman F, Arghandawi S, Pearl V, Benjamin N, Loukogeorgakis S, Macallister R, Hobbs AJ, Webb AJ, Ahluwalia A. Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite-derived NO. Hypertension. 2010 Aug;56(2):274-81. doi: 10.1161/HYPERTENSIONAHA.110.153536. Epub 2010 Jun 28.

    PMID: 20585108BACKGROUND
  • Kapil V, Rathod KS, Khambata RS, Bahra M, Velmurugan S, Purba A, S Watson D, Barnes MR, Wade WG, Ahluwalia A. Sex differences in the nitrate-nitrite-NO* pathway: Role of oral nitrate-reducing bacteria. Free Radic Biol Med. 2018 Oct;126:113-121. doi: 10.1016/j.freeradbiomed.2018.07.010. Epub 2018 Jul 20.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Urine, saliva and plasma

MeSH Terms

Conditions

Cardiovascular Diseases

Study Officials

  • Amrita Ahluwalia, PhD

    Queen Mary University London

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Vascular Pharmacology

Study Record Dates

First Submitted

April 20, 2012

First Posted

April 24, 2012

Study Start

June 1, 2012

Primary Completion

January 1, 2014

Study Completion

June 1, 2017

Last Updated

December 21, 2016

Record last verified: 2016-12

Locations